P. Graham

R. Fisher, S. Vinod, D. Joseph, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Proteomics discovery of chemoresistant biomarkers for ovarian cancer therapy

W. Duan, Yong Li, Li Wang, 2016, Expert review of proteomics.

CD44 variant 6 is associated with prostate cancer metastasis and chemo‐/radioresistance

W. Duan, Yong Li, S. Shigdar, 2014, The Prostate.

Targeting MicroRNAs in Prostate Cancer Radiotherapy

Yong Li, Joseph Bucci, Jie Ni, 2017, Theranostics.

A Standardized and Reproducible Urine Preparation Protocol for Cancer Biomarkers Discovery

Yong Li, J. Beretov, V. Wasinger, 2014, Biomarkers in cancer.

Communicating breast cancer treatment complication risks: When words are likely to fail

P. Graham, L. Browne, Rowena Martin, 2009 .

Absolute quantification of human tear lactoferrin using multiple reaction monitoring technique with stable-isotopic labeling.

Yong Li, P. Russell, Anna M. Fitzgerald, 2015, Analytical biochemistry.

Post‐translation modification of proteins in tears

Yong Li, Anna M. Fitzgerald, V. Wasinger, 2010, Electrophoresis.

Collaborative implementation of stereotactic ablative body radiotherapy: A model for the safe implementation of complex radiotherapy techniques in Australia

S. Vinod, N. Aherne, Y. Chin, 2019, Asia-Pacific journal of clinical oncology.

Targeted alpha therapy for cancer

Yong Li, J. Kearsley, B. Allen, 2004, Physics in medicine and biology.

Tumour anti-vascular alpha therapy: a mechanism for the regression of solid tumours in metastatic cancer

B. Allen, S. Rizvi, P. Graham, 2007, Physics in medicine and biology.

What happens to testosterone after prostate radiation monotherapy and does it matter?

T. Pickles, P. Graham, 2002, The Journal of urology.

Cancer Stem Cells “The Root of Radioresistance” in Prostate Cancer Radiotherapy

Yong Li, J. Kearsley, J. Bucci, 2013 .

Exosomes and breast cancer drug resistance

W. Duan, Yong Li, Xupeng Bai, 2020, Cell Death & Disease.

Cancer stem cells in prostate cancer radioresistance.

Yong Li, J. Bucci, J. Beretov, 2019, Cancer letters.

Intralesional targeted alpha therapy for metastatic melanoma

Yong Li, J. Kearsley, B. Allen, 2005, Cancer biology & therapy.

Re-inventing the wheel: assessing malignant spinal cord compression outcomes.

P. Graham, 1997, Australasian radiology.

A Clinician's Guide to Cancer-Derived Exosomes: Immune Interactions and Therapeutic Implications

Yong Li, J. Bucci, Y. Chin, 2020, Frontiers in Immunology.

Laryngeal tumours and radiotherapy dose to the cricopharyngeus are predictive of death from aspiration pneumonia.

H. Quon, I. Cook, Rashmi Gupta, 2017, Oral oncology.

Clinical utility of a functional lumen imaging probe in management of dysphagia following head and neck cancer therapies

H. Quon, I. Cook, P. Graham, 2017, Endoscopy.

Combination Therapy with the Histone Deacetylase Inhibitor LBH589 and Radiation Is an Effective Regimen for Prostate Cancer Cells

Yong Li, J. Kearsley, C. Power, 2013, PloS one.

Adenoid cystic carcinoma of the lung: Response to tamoxifen after chemoradiation

M. Links, P. Graham, E. Hau, 2016, Asia-Pacific journal of clinical oncology.

A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal-cord compression treated by radiotherapy: TROG 01.05 Superdex study.

G. Goozée, B. Hickey, A. Capp, 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

Low levels of ATM in breast cancer patients with clinical radiosensitivity

M. McKay, M. Lavin, R. Clarke, 2010, Genome Integrity.

Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3–07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study

T. Whelan, I. Kunkler, J. Maduro, 2022, The Lancet.

Videofluoroscopic Swallow Examination Does Not Accurately Detect Cricopharyngeal Radiation Strictures

Ianessa A. Humbert, H. Quon, I. Humbert, 2016, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Assessment of DNA methylation profiling and copy number variation as indications of clonal relationship in ipsilateral and contralateral breast cancers to distinguish recurrent breast cancer from a second primary tumour

Samantha E. Boyle, T. Speed, S. Fox, 2015, BMC Cancer.

The CD44 Isoforms in Prostate Cancer Metastasis and Progression

Yong Li, J. Kearsley, J. Bucci, 2013 .

Endobronchial brachytherapy in the management of lung malignancies: 20 years of experience in an Australian center.

J. Bucci, P. Graham, A. Bece, 2018, Brachytherapy.

Radioresistant malignant myoepithelioma of the breast with high level of ataxia telangiectasia mutated protein

R. Clarke, M. Lavin, J. Kearsley, 2009, Journal of medical imaging and radiation oncology.

Persistent dysphagia after head and neck radiotherapy: a common and under-reported complication with significant effect on non-cancer-related mortality.

I. Cook, P. Graham, J. Maclean, 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

Metachronous bilateral primary low‐grade mucosa‐associated lymphoid tissue non‐Hodgkins lymphoma of the breast

E. Millar, P. Graham, C. Theocharous, 2009 .

Tolerance of nicotinamide and carbogen with radiation therapy for glioblastoma.

G. Duncan, T. Pickles, I. Syndikus, 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The long term impact of breast cosmetic and functional outcomes on quality of life

G. Papadatos, J. Kearsley, E. Millar, 2012 .

Re: Hermann et al., low testosterone levels and quality of life.

G. Duncan, T. Pickles, P. Graham, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Metastatic Cutaneous Squamous Cell Carcinoma to the Axilla: A Review of Patient Outcomes and Implications for Future Practice

P. Graham, L. Browne, N. Beydoun, 2012, World journal of oncology.

Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy

Yong Li, J. Kearsley, J. Bucci, 2014, Cancer and Metastasis Reviews.

Survival prediction in triple negative breast cancer using multiple instance learning of histopathological images

Junzhou Huang, J. Jonnagaddala, J. Beretov, 2022, Scientific Reports.

Tear fluid protein biomarkers.

Yong Li, M. Madigan, J. Kearsley, 2013, Advances in clinical chemistry.

A multicentre observational study evaluating image-guided radiotherapy for more accurate partial-breast intensity-modulated radiotherapy: comparison with standard imaging technique

H. Bartelink, P. Evans, J. Yarnold, 2014 .

Cancer stem cell in breast cancer therapeutic resistance.

Yong Li, J. Beretov, Xupeng Bai, 2018, Cancer treatment reviews.

Inhalation aromatherapy during radiotherapy: results of a placebo-controlled double-blind randomized trial.

P. Graham, L. Browne, J. Graham, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized, paired comparison of No-Sting Barrier Film versus sorbolene cream (10% glycerine) skin care during postmastectomy irradiation.

C. Fox, A. Capp, P. Graham, 2004, International journal of radiation oncology, biology, physics.

Metastatic cutaneous squamous cell carcinoma to parotid nodes: The role of bolus with adjuvant radiotherapy

P. Graham, L. Browne, A. Pramana, 2012, Journal of medical imaging and radiation oncology.

Tumour Stroma Ratio Assessment Using Digital Image Analysis Predicts Survival in Triple Negative and Luminal Breast Cancer

E. Millar, A. Swarbrick, J. Beretov, 2020, Cancers.

Proteomics discovery of radioresistant cancer biomarkers for radiotherapy.

D. Gillatt, Yong Li, J. Bucci, 2015, Cancer letters.

Three-dimensional dose distribution of tangential breast irradiation: results of a multicentre phantom dosimetry study.

J. Boyages, W. Beckham, C. Fox, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Quantitative Evaluation of Head and Neck Cancer Treatment-Related Dysphagia in the Development of a Personalized Treatment Deintensification Paradigm.

T. McNutt, H. Quon, Z. Cheng, 2017, International journal of radiation oncology, biology, physics.

Endoscopic dilatation improves long-term dysphagia following head and neck cancer therapies: a randomized control trial.

H. Quon, I. Cook, P. Graham, 2018, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Esophageal Dysmotility in Patients following Total Laryngectomy

H. Quon, I. Cook, P. Graham, 2018, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.

W. Duan, Yong Li, S. Shigdar, 2013, The international journal of biochemistry & cell biology.

Urinary biomarkers in prostate cancer detection and monitoring progression.

Yong Li, J. Beretov, V. Wasinger, 2017, Critical reviews in oncology/hematology.

Exosomes in Cancer Radioresistance

Yong Li, J. Bucci, P. Graham, 2019, Front. Oncol..

Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance.

Yong Li, J. Bucci, P. Graham, 2015, Critical reviews in oncology/hematology.

Cancer stem cells in prostate cancer chemoresistance.

W. Duan, Yong Li, J. Kearsley, 2014, Current cancer drug targets.

TILs Immunophenotype in Breast Cancer Predicts Local Failure and Overall Survival: Analysis in a Large Radiotherapy Trial with Long-Term Follow-Up

R. Whan, S. O'toole, E. Millar, 2020, Cancers.

Recent advances of small extracellular vesicle biomarkers in breast cancer diagnosis and prognosis

Yong Li, J. Beretov, V. Wasinger, 2023, Molecular Cancer.

Quality Assessment and Comparison of Plasma-Derived Extracellular Vesicles Separated by Three Commercial Kits for Prostate Cancer Diagnosis

Yong Li, J. Bucci, Ying Zhu, 2020, International journal of nanomedicine.

Extracellular vesicles: the next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis

Yong Li, J. Bucci, Ying Zhu, 2020, Theranostics.

In Vitro and In Vivo Prostate Cancer Metastasis and Chemoresistance Can Be Modulated by Expression of either CD44 or CD147

Yong Li, M. Madigan, J. Kearsley, 2012, PloS one.

Low dose histone deacetylase inhibitor, LBH589, potentiates anticancer effect of docetaxel in epithelial ovarian cancer via PI3K/Akt pathway in vitro.

Yong Li, J. Kearsley, Li Wang, 2013, Cancer letters.

Acquisition of epithelial–mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance

Yong Li, J. Kearsley, J. Bucci, 2013, Cell Death and Disease.

Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer

W. Duan, Yong Li, Li Wang, 2016, Oncotarget.

Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53

S. O'toole, G. Papadatos, R. Sutherland, 2011, British Journal of Cancer.

miR-139-5p Modulates Radiotherapy Resistance in Breast Cancer by Repressing Multiple Gene Networks of DNA Repair and ROS Defense.

A. Harris, M. Pajic, S. O'toole, 2018, Cancer research.

Triple-negative breast cancer therapeutic resistance: Where is the Achilles' heel?

Yong Li, J. Beretov, Xupeng Bai, 2020, Cancer letters.

Stage I Non-small Cell Lung Cancer: Results for Surgery in a Patterns-of-Care Study in Sydney and for High-Dose Concurrent End-Phase Boost Accelerated Radiotherapy

S. Vinod, P. Graham, A. Hui, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Samantha E. Boyle, T. Speed, S. Fox, 2015, BMC Cancer.

A brief review on the biological effects of radiation on cells

P. Graham, E. Hau, 2012 .

Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression

Yong Li, J. Beretov, Xupeng Bai, 2019, BMC Cancer.

Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.

S. O'toole, G. Papadatos, R. Sutherland, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analysis of patient survival in a Phase I trial of systemic targeted α-therapy for metastatic melanoma.

B. Allen, S. Rizvi, C. Apostolidis, 2011, Immunotherapy.

The evolving roles and controversies of radiotherapy in the treatment of glioblastoma

E. Koh, P. Graham, E. Hau, 2016, Journal of medical radiation sciences.

Role of the EpCAM (CD326) in prostate cancer metastasis and progression

Yong Li, S. Shigdar, P. Graham, 2012, Cancer and Metastasis Reviews.

Liquid biopsy in ovarian cancer: recent advances in circulating extracellular vesicle detection for early diagnosis and monitoring progression

Jie Ni, Peter Graham, Yong Li, 2019, Theranostics.

Proteomics for breast cancer urine biomarkers.

Yong Li, J. Kearsley, E. Millar, 2014, Advances in clinical chemistry.

Compression prophylaxis may increase the potential for flight-associated lymphoedema after breast cancer treatment.

P. Graham, Peter Graham, 2002, Breast.

The complex relationship between lung tumor volume and survival in patients with non-small cell lung cancer treated by definitive radiotherapy: a prospective, observational prognostic factor study of the Trans-Tasman Radiation Oncology Group (TROG 99.05).

Shalini K Vinod, S. Vinod, D. Joseph, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target

Yong Li, J. Beretov, Xupeng Bai, 2019, Front. Oncol..

Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approach

D. Gillatt, Yong Li, J. Bucci, 2017, Scientific Reports.

International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breast.

T. Whelan, I. Kunkler, J. Maduro, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A paired, double-blind, randomized comparison of a moisturizing durable barrier cream to 10% glycerine cream in the prophylactic management of postmastectomy irradiation skin care: trans Tasman Radiation Oncology Group (TROG) 04.01.

A. Capp, G. Delaney, P. Graham, 2013, International journal of radiation oncology, biology, physics.

The impact of breast cosmetic and functional outcomes on quality of life: long-term results from the St. George and Wollongong randomized breast boost trial

G. Papadatos, J. Kearsley, E. Millar, 2013, Breast Cancer Research and Treatment.

Breast irradiation causes pallor in the nipple‐areolar complex in women with Celtic skin type (result from the St. George and Wollongong randomised breast boost trial)

Y. Chin, P. Graham, E. Hau, 2014, Journal of medical imaging and radiation oncology.

CD44 is a biomarker associated with human prostate cancer radiation sensitivity

Yong Li, J. Kearsley, C. Power, 2011, Clinical & Experimental Metastasis.

Tattoo allergy in patients receiving adjuvant radiotherapy for breast cancer.

P. Graham, J. Nankervis, S. Sewak, 1999, Australasian radiology.

Placing the boost in breast-conservation radiotherapy: A review of the role, indications and techniques for breast-boost radiotherapy.

A. Fourquet, P. Graham, 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

The effect of oral sucralfate on the acute proctitis associated with prostate radiotherapy: a double-blind, randomized trial.

R. Fisher, H. Mameghan, J. Kearsley, 2001, International journal of radiation oncology, biology, physics.

Proposal for a gold standard for cosmetic evaluation after breast conserving therapy: Results from the St George and Wollongong Breast Boost trial

Jaime S. Cardoso, M. Cardoso, Y. Chin, 2017, Journal of medical imaging and radiation oncology.

Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer.

Yong Li, J. Beretov, P. Graham, 2019, Critical reviews in oncology/hematology.

CD44 variant 6 is associated with prostate cancer growth and chemo-/radiotherapy response in vivo.

W. Duan, Yong Li, J. Bucci, 2020, Experimental cell research.

Why a breast boost should remain a controversial aspect of routine breast conservation management in Australia and New Zealand in 2002.

C. Fox, A. Capp, G. Delaney, 2003, Australasian radiology.

Activation of the eIF2α/ATF4 axis drives triple-negative breast cancer radioresistance by promoting glutathione biosynthesis

Yong Li, J. Beretov, Shanping Wang, 2021, Redox biology.

Multiplexed immunofluorescence identifies high stromal CD68+PD-L1+ macrophages as a predictor of improved survival in triple negative breast cancer

R. Whan, J. Beretov, J. Lynch, 2021, Scientific Reports.

Letters from the radiation oncologist: do referring doctors give a damn?

G. Wilson, P. Graham, 1998, Australasian radiology.

Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy

Yong Li, J. Kearsley, J. Bucci, 2014, Cancer and Metastasis Reviews.

hist2RNA: An Efficient Deep Learning Architecture to Predict Gene Expression from Breast Cancer Histopathology Images

Raktim Kumar Mondol, E. Meijering, A. Sowmya, 2023, Cancers.

Monitoring Prostate Tumor Growth in an Orthotopic Mouse Model Using Three-Dimensional Ultrasound Imaging Technique12

Yong Li, P. Graham, P. Cozzi, 2016, Translational oncology.

Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo

W. Duan, Yong Li, J. Bucci, 2018, BMC Cancer.

Opioid substitution to reduce adverse effects in cancer pain management

P. Graham, 1999, The Medical journal of Australia.

Absence of adverse early quality of life outcomes of radiation therapy in breast conservation therapy for early breast cancer.

A. Steigler, G. Delaney, C. Wratten, 2005, Australasian radiology.

Pion conformal radiation of prostate cancer: results of a randomized study.

W. J. Morris, G. Duncan, T. Pickles, 1999, International journal of radiation oncology, biology, physics.

Role of the EpCAM (CD326) in prostate cancer metastasis and progression

W. Duan, Yong Li, S. Shigdar, 2012, Cancer and Metastasis Reviews.

Supraclavicular radiotherapy must be limited laterally by the coracoid to avoid significant adjuvant breast nodal radiotherapy lymphoedema risk.

E. Millar, P. Graham, L. Browne, 2006, Australasian radiology.

Splenic irradiation for hairy cell leukaemia.

P. Graham, M. Al-Moundhri, 1997, Australasian Radiology.

Four-week arc radiotherapy for B2-C prostate cancer: the need for prospective evaluation of short fractionation schemes.

W. J. Morris, T. Pickles, P. Graham, 1997, Australasian radiology.